Loading...
Bluejay Diagnostics Inc (BJDX) is not a good buy for a beginner, long-term investor with $50,000-$100,000 available for investment. The stock shows bearish technical indicators, no positive catalysts, weak financial performance, and lacks any strong trading signals or influential support. Given the user's impatience and preference for long-term investments, this stock does not align with their goals.
The technical indicators for BJDX are bearish. The MACD histogram is negative and expanding downward, RSI is neutral but leaning toward oversold territory, and moving averages are bearish with SMA_200 > SMA_20 > SMA_5. The stock is trading below key support levels, with the next support at 2.545, indicating potential further downside.
NULL identified. There is no recent news, no significant insider or hedge fund activity, and no influential political or congressional trading data.
The stock has experienced a significant regular market decline of -8.72% and is showing bearish technical indicators. Financial performance is weak, with negative net income, declining EPS (-86.91% YoY), and no revenue growth.
In Q3 2025, the company's revenue remained at 0 with no growth. Net income improved slightly by 7.81% YoY but remains negative at -1,597,632. EPS dropped significantly by -86.91% YoY to -4.06, indicating worsening profitability. Gross margin remains at 0, showing no operational efficiency.
No analyst rating or price target changes were provided.
